# Medicare Advantage Drug Coverage Changes for 2027 Review your prescription plans before December 7 to avoid unexpected 2027 costs. - **Source:** [SavingAdvice.com Blog](https://brifing.si/source/0a5be9fd-36c9-42ed-8bc4-90f6e843d3b4) - **Published:** 2026-10-18 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/3765ee72-33c3-4854-bb5c-26c6a3023c2e ## Medicare Price Negotiations 2027 Starting January 1, 2027, Medicare will implement negotiated prices for 15 additional high-cost medications. While these negotiations aim to lower costs, individual expenses remain tied to specific plan formularies, deductibles, and pharmacy networks. Beneficiaries should not assume that current coverage terms will persist, as insurance plans frequently adjust their drug tiers annually. ## Semaglutide Coverage and Restrictions Ozempic, Wegovy, and Rybelsus are included in the 2027 negotiated price list, impacting approximately 2.3 million Part D enrollees. However, Medicare generally excludes weight-loss medications from coverage. Patients must verify if their specific diagnosis qualifies under 2027 plan rules, as negotiated pricing does not guarantee reimbursement for every individual prescription. ## Respiratory Medication Cost Planning Trelegy Ellipta and Breo Ellipta, used for COPD and asthma, are among the selected medications for 2027. Retirees relying on these daily inhalers should compare estimated annual costs across different plans. Small changes in copayments or cost-sharing requirements can significantly impact monthly budgets, making it vital to evaluate total expenses beyond just premiums. ## Gastrointestinal and Diabetes Management Linzess and Tradjenta are subject to new negotiated pricing effective in 2027. For diabetes patients managing multiple prescriptions, these changes require careful review of plan design. Beneficiaries should check for prior authorization requirements or quantity restrictions, as a plan with a lower monthly premium might result in higher overall costs for specific medications. ## Specialized Treatment Access Risks Xifaxan, Ibrance, and Vraylar are included in the 2027 price negotiations. For patients treating cancer or mental health conditions, maintaining access to established providers and medications is critical. Before switching plans, verify that your oncology or mental health team remains in the network and that all necessary authorizations are clearly understood for 2027. ## Part D Financial Thresholds The maximum Medicare Part D deductible will increase from $615 in 2026 to $700 in 2027. Additionally, the annual out-of-pocket threshold for covered medications rises to $2,400. Once this limit is reached, beneficiaries typically pay nothing for the remainder of the year, making it essential to calculate total annual costs before enrolling. ## Navigating Open Enrollment Deadlines Medicare Open Enrollment ends on December 7. To prepare, gather all current prescriptions, dosages, and your Annual Notice of Change document. Utilize the official Medicare Plan Finder to estimate expenses accurately. If you require personalized guidance, free counseling is available through your State Health Insurance Assistance Program to help navigate these complex changes. ## Strategic Benefit Review Importance Proactive review of Medicare Advantage coverage is essential to avoid financial surprises in 2027. Relying on past coverage patterns or marketing advertisements can lead to unexpected costs. By analyzing formularies and pharmacy arrangements now, retirees can protect their access to necessary treatments while effectively managing their healthcare spending for the upcoming year. ## Sources covering this story - https://www.savingadvice.com/articles/2026/10/18/10753879_medicare-advantage-drug-coverage-2027-medications-check.html — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._